Trials / Conditions / Poor Prognosis Metastatic Gestational Trophoblastic Tumor

Poor Prognosis Metastatic Gestational Trophoblastic Tumor

5 registered clinical trials studyying Poor Prognosis Metastatic Gestational Trophoblastic Tumor.

Status	Trial	Sponsor	Phase
Withdrawn	Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant NCT01558778	Roswell Park Cancer Institute	N/A
Completed	Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia NCT01484015	Wake Forest University Health Sciences	Phase 1
Terminated	Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload NCT01159067	City of Hope Medical Center	Phase 2
Completed	Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant NCT00795769	Fred Hutchinson Cancer Center	Phase 2
Completed	Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem NCT00408681	Fred Hutchinson Cancer Center	N/A